Alnylam Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …
Biotechnology
US, Cambridge [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of ALNY's Analysis
CIK: 1178670 CUSIP: 02043Q107 ISIN: US02043Q1076 LEI: - UEI: -
Secondary Listings